EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cardiac implantable electronic device‐induced tricuspid regurgitation: Implications and management

Sean P Murphy iD, Jeanney Lew, Evin Yucel, Jagmeet Singh, Theofanie Mela

Journal of Cardiovascular Electrophysiology · 2024

DOI: 10.1111/jce.16251 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Sean P Murphy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Defibrillators, Implantable, Pacemaker, Artificial. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tricuspid regurgitation (TR) secondary to cardiac implantable electronic devices (CIEDs) has been well documented and is associated with worse cardiovascular outcomes. A variety of mechanisms have been proposed including lead‐induced mechanical disruption of the tricuspid valvular or subvalvular apparatus and pacing‐induced electrical dyssynchrony. Patient characteristics such as age, sex, baseline atrial fibrillation, and pre‐existing TR have not been consistent predictors of CIED‐induced TR. While two‐dimensional echocardiography is helpful in assessing the severity of TR, three‐dimensional echocardiography has significantly improved accuracy in identifying the etiology of TR and whether lead position contributes to TR. Three‐dimensional echocardiography may therefore play a future role in optimizing lead positioning during implant to reduce the risk of CIED‐induced TR. Optimal lead management strategies in addition to percutaneous interventions and surgery in alleviating TR are very important.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyDefibrillators, ImplantablePacemaker, ArtificialHumansTricuspid ValveRisk FactorsTreatment OutcomeEchocardiography, Three-Dimensional

Stichwörter der Autor:innen

CIEDcardiac implantable electronic devicelead‐induced tricuspid regurgitationtricuspid regurgitation

Autor:innen und Institutionen

  • Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • The Demoulas Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Sean P Murphy

Zitieren

APA

Murphy, S. P., Lew, J., Yucel, E., Singh, J., & Mela, T. (2024). Cardiac implantable electronic device‐induced tricuspid regurgitation: Implications and management. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16251

Vancouver

Murphy SP, Lew J, Yucel E, Singh J, Mela T. Cardiac implantable electronic device‐induced tricuspid regurgitation: Implications and management. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16251

BibTeX
@article{Murphy2024,
  author = {Murphy, Sean P and Lew, Jeanney and Yucel, Evin and Singh, Jagmeet and Mela, Theofanie},
  title = {Cardiac implantable electronic device‐induced tricuspid regurgitation: Implications and management},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  doi = {10.1111/jce.16251}
}
Kostenlos starten →